Literature DB >> 7775107

Albumin movement out of the subretinal space after experimental retinal detachment.

A Takeuchi1, G Kricorian, M F Marmor.   

Abstract

PURPOSE: The subretinal fluid of serous retinal detachments contains protein, but little is known about its origin and fate. The authors designed experiments to study the rate and route of albumin movement out of the subretinal space.
METHODS: Experimental retinal detachments were made in Dutch rabbits by injecting Hanks' balanced salt solution containing serum levels (approximately 30 mg/ml) of fluorescein isothiocyanate (FITC) albumin into the subretinal space through a micropipette. Subretinal, vitreous, and serum fluid samples were withdrawn 0 to 4 hours later through a similar micropipette and were analyzed for osmolality, FITC albumin content (by fluorophotometry) and FITC+native albumin content (by gel electrophoresis). Sodium iodate was injected intravenously in some rabbits to damage the retinal pigment epithelium (RPE).
RESULTS: Albumin injected into the subretinal fluid diffused steadily into the vitreous, and its concentration decreased by approximately 5% per hour. This rate was unaffected by RPE damage. Albumin did not move into the bloodstream unless the RPE was damaged with sodium iodate, and then it crossed the RPE at approximately 25% of the rate at which it moved into the vitreous. Subretinal fluid osmolality remained within the range of 293 to 294 mOsm/kg despite protein movement and the continual absorption of fluid from the detachments.
CONCLUSIONS: These results show that albumin in the subretinal space diffuses readily into the vitreous, and subretinal osmolality changes are rapidly equilibrated with the vitreous. Albumin does not cross normal RPE, and it crosses iodate-damaged RPE more slowly than it crosses retina. Thus, there must be a constant supply of albumin if high subretinal concentrations are to be sustained in clinical serous detachments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775107

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  RPE barrier breakdown in diabetic retinopathy: seeing is believing.

Authors:  Hui-Zhuo Xu; Zhiming Song; Shuhua Fu; Meili Zhu; Yun-Zheng Le
Journal:  J Ocul Biol Dis Infor       Date:  2011-12-31

2.  Significance of outer blood-retina barrier breakdown in diabetes and ischemia.

Authors:  Hui-Zhuo Xu; Yun-Zheng Le
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-05       Impact factor: 4.799

Review 3.  Mechanisms of fluid accumulation in retinal edema.

Authors:  M F Marmor
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

4.  Efficacy of Intravitreal Dexamethasone Implant in Different Patterns of Diabetic Macular Edema.

Authors:  Claudio Furino; Alfredo Niro; Michele Reibaldi; Francesco Boscia; Giovanni Alessio
Journal:  J Ophthalmic Vis Res       Date:  2020-10-25

Review 5.  Ocular Barriers and Their Influence on Gene Therapy Products Delivery.

Authors:  Bastien Leclercq; Dan Mejlachowicz; Francine Behar-Cohen
Journal:  Pharmaceutics       Date:  2022-05-06       Impact factor: 6.525

6.  Smokestack leak in central serous chorioretinopathy.

Authors:  Dhiren Bujarborua; Pran N Nagpal; Manab Deka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-15       Impact factor: 3.117

7.  The outer limiting membrane (OLM) revisited: clinical implications.

Authors:  S Omri; B Omri; M Savoldelli; L Jonet; B Thillaye-Goldenberg; G Thuret; P Gain; J C Jeanny; P Crisanti; Francine Behar-Cohen
Journal:  Clin Ophthalmol       Date:  2010-04-26

8.  FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye.

Authors:  Hyuncheol Kim; Shaun B Robinson; Karl G Csaky
Journal:  Mol Vis       Date:  2009-12-16       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.